230 related articles for article (PubMed ID: 16553324)
1. Posaconazole treatment of refractory eumycetoma and chromoblastomycosis.
Negroni R; Tobón A; Bustamante B; Shikanai-Yasuda MA; Patino H; Restrepo A
Rev Inst Med Trop Sao Paulo; 2005; 47(6):339-46. PubMed ID: 16553324
[TBL] [Abstract][Full Text] [Related]
2. Posaconazole.
Keating GM
Drugs; 2005; 65(11):1553-67; discussion 1568-9. PubMed ID: 16033292
[TBL] [Abstract][Full Text] [Related]
3. Posaconazole: an extended-spectrum triazole antifungal agent.
Schiller DS; Fung HB
Clin Ther; 2007 Sep; 29(9):1862-86. PubMed ID: 18035188
[TBL] [Abstract][Full Text] [Related]
4. Treatment of tropical mycoses.
Restrepo A
J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S91-102. PubMed ID: 8077517
[TBL] [Abstract][Full Text] [Related]
5. [The latest data on posaconazole].
Paugam A
Med Mal Infect; 2007 Feb; 37(2):71-6. PubMed ID: 17267154
[TBL] [Abstract][Full Text] [Related]
6. Activity of posaconazole in the treatment of central nervous system fungal infections.
Pitisuttithum P; Negroni R; Graybill JR; Bustamante B; Pappas P; Chapman S; Hare RS; Hardalo CJ
J Antimicrob Chemother; 2005 Oct; 56(4):745-55. PubMed ID: 16135526
[TBL] [Abstract][Full Text] [Related]
7. Last generation triazoles for imported eumycetoma in eleven consecutive adults.
Crabol Y; Poiree S; Bougnoux ME; Maunoury C; Barete S; Zeller V; Arvieux C; Pineau S; Amazzough K; Lecuit M; Lanternier F; Lortholary O;
PLoS Negl Trop Dis; 2014 Oct; 8(10):e3232. PubMed ID: 25299610
[TBL] [Abstract][Full Text] [Related]
8. Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections.
Herbrecht R
Int J Clin Pract; 2004 Jun; 58(6):612-24. PubMed ID: 15311563
[TBL] [Abstract][Full Text] [Related]
9. Unusual presentation of chromoblastomycosis due to Cladophialophora carrionii in a renal and pancreas transplant recipient patient successfully treated with posaconazole and surgical excision.
Dupont C; Duong TA; Mallet S; Mamzer-Bruneel MF; Thervet E; Bougnoux ME; Dupont B
Transpl Infect Dis; 2010 Apr; 12(2):180-3. PubMed ID: 20002358
[TBL] [Abstract][Full Text] [Related]
10. Successful therapy with ABLC, surgery and posaconazole for Rhizopus microsporus var. rhizopodiformis liver eumycetoma in a child with acute leukaemia.
Sedlacek P; Vavra V; Masova I; Codl D; Laznickova T; Malaskova L; Nyc O; Stary J
Mycoses; 2009 May; 52(3):276-9. PubMed ID: 18643916
[TBL] [Abstract][Full Text] [Related]
11. Difficult mycoses of the skin: advances in the epidemiology and management of eumycetoma, phaeohyphomycosis and chromoblastomycosis.
Garnica M; Nucci M; Queiroz-Telles F
Curr Opin Infect Dis; 2009 Dec; 22(6):559-63. PubMed ID: 19773651
[TBL] [Abstract][Full Text] [Related]
12. Posaconazole: a broad-spectrum triazole antifungal.
Torres HA; Hachem RY; Chemaly RF; Kontoyiannis DP; Raad II
Lancet Infect Dis; 2005 Dec; 5(12):775-85. PubMed ID: 16310149
[TBL] [Abstract][Full Text] [Related]
13. Posaconazole therapy for chronic refractory coccidioidomycosis.
Stevens DA; Rendon A; Gaona-Flores V; Catanzaro A; Anstead GM; Pedicone L; Graybill JR
Chest; 2007 Sep; 132(3):952-8. PubMed ID: 17573510
[TBL] [Abstract][Full Text] [Related]
14. Extensive long-standing chromomycosis due to Fonsecaea pedrosoi: three cases with relevant improvement under voriconazole therapy.
Criado PR; Careta MF; Valente NY; Martins JE; Rivitti EA; Spina R; Belda W
J Dermatolog Treat; 2011 Jun; 22(3):167-74. PubMed ID: 20666671
[TBL] [Abstract][Full Text] [Related]
15. Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections.
Raad II; Graybill JR; Bustamante AB; Cornely OA; Gaona-Flores V; Afif C; Graham DR; Greenberg RN; Hadley S; Langston A; Negroni R; Perfect JR; Pitisuttithum P; Restrepo A; Schiller G; Pedicone L; Ullmann AJ
Clin Infect Dis; 2006 Jun; 42(12):1726-34. PubMed ID: 16705579
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of posaconazole in the long-term treatment of azole-refractory oropharyngeal and esophageal candidiasis in patients with HIV infection.
Vazquez JA; Skiest DJ; Tissot-Dupont H; Lennox JL; Boparai N; Isaacs R
HIV Clin Trials; 2007; 8(2):86-97. PubMed ID: 17507324
[TBL] [Abstract][Full Text] [Related]
17. Scedosporium apiospermum eumycetoma successfully treated with oral voriconazole: report of a case and review of the Brazilian reports on scedosporiosis.
Oliveira Fde M; Unis G; Hochhegger B; Severo LC
Rev Inst Med Trop Sao Paulo; 2013; 55(2):121-3. PubMed ID: 23563766
[TBL] [Abstract][Full Text] [Related]
18. Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant.
Alexander BD; Perfect JR; Daly JS; Restrepo A; Tobón AM; Patino H; Hardalo CJ; Graybill JR
Transplantation; 2008 Sep; 86(6):791-6. PubMed ID: 18813103
[TBL] [Abstract][Full Text] [Related]
19. Posaconazole: Use in the Prophylaxis and Treatment of Fungal Infections.
Clark NM; Grim SA; Lynch JP
Semin Respir Crit Care Med; 2015 Oct; 36(5):767-85. PubMed ID: 26398542
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of chromoblastomycosis and phaeohyphomycosis].
Dobiáš R; Havlíček V
Klin Mikrobiol Infekc Lek; 2020 Jun; 26(2):62-68. PubMed ID: 33389743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
